l-carnitine what does it do for the body | Linus Pauling Institute 💥 L-Carnitine: The Energy Booster

Phase 2 and Phase 3 trial data Major clinical trials: Phase 2 (24-week trial, 2008): 203 obese participants Three dose groups: 0.25mg, 0.5mg, 1.0mg daily Placebo-controlled, randomized Primary outcome: Weight loss percentage Phase 2 results: Key findings: Dose-dependent weight loss 1mg dose: Average 23 lbs lost (starting weight ~220 lbs) Best responders: 15-20% weight loss Comparable to semaglutide 2.4mg But higher dropout due to side effects Phase 3 trials (planned but never completed): Intended for FDA approval Halted due to cardiovascular concerns Increased heart rate 5-10 bpm average Blood pressure elevation 2-5 mmHg Risk-benefit ratio questioned Development suspended 2010 Long-term data (limited): 1-year extension studies showed sustained loss Weight plateau at 6-9 months Some regain if discontinued No controlled trials beyond 1 year Safety concerns prevented longer studies Compare to semaglutide trials and tirzepatide results

Travlos, G

KhanKNKitajimaMImamuraTHirakiKFujishitaASekineIet al

ROS-generating nanoplatforms as selective and tunable therapeutic weapons against cancer

Sato et al., 2001

Vitamin Injections Vitamin injections, like popular B12 shots in Muncie, are smaller doses of essential nutrients delivered via syringe